Recently Viewed
Clear All
Bidding Date
14-May-2025 to
16-May-2025
Issue Size
₹29.75 Cr
Price Band
₹96 to ₹101
Allotment date
19-May-2025
Listing date
21-May-2025
Lot size
1200
No. of shares
29,46,000
Fresh issue/OFS
₹29.75 Cr /--
Accretion Pharmaceuticals Limited, established in 2012, operates as a pharmaceutical Contract Development and Manufacturing Organization (CDMO), primarily engaged in the manufacturing and marketing of a wide range of dosage forms including tablets, capsules, oral liquids, external preparations (such as ointments, creams, gels, lotions, medicated shampoos, mouthwashes, and dusting powders), and oral powders like sachets and dry syrups. The company conducts its business through multiple models—direct sales in the domestic and export markets, as well as contract manufacturing and loan license arrangements for third-party marketers. Geographically, Gujarat remains the company’s most significant market, contributing over 85% of domestic revenue consistently over the years. Product-wise, the majority of the revenue comes from tablets, oral liquids, and capsules, with tablets alone contributing approximately 40% of the revenue in recent financial years.
Category
Status
QIBs
--
NIIs
--
Retail
--
Others
--
Total
3.9x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Safety Controls & Devices | 75 - 80 | 06-Apr-2026 to 08-Apr-2026 |
| Emiac Technologies | 93 - 98 | 27-Mar-2026 to 08-Apr-2026 |
| Vivid Electromech | 528 - 555 | 25-Mar-2026 to 30-Mar-2026 |
| Amir Chand Jagdish Kumar (Exports) | 201 - 212 | 24-Mar-2026 to 27-Mar-2026 |
The issue size of Accretion Pharmaceuticals is ₹29.75 Cr.
Accretion Pharmaceuticals falls into Pharmaceuticals industry.
The Accretion Pharmaceuticals IPO will be listed on BSE.
The open and close dates for the Accretion Pharmaceuticals are 14-May-2025 & 16-May-2025.
The price band for the Accretion Pharmaceuticals ipo is ₹96 to ₹101
The listing date of Accretion Pharmaceuticals IPO is 21-May-2025.
The purpose of this IPO is to raise fresh capital.
Accretion Pharmaceuticals total subscription ratio is 3.9X.
Key financial of the Accretion Pharmaceuticals are:
| Accretion Pharmaceuticals | FY-25 | FY-24 |
|---|---|---|
| Revenue (₹ Cr) | 57.38 | 13.35 |
| EBIT (₹ Cr) | 11.11 | 2.34 |
| Proft after Tax (₹ Cr) | 6.79 | 1.49 |
| Debt (₹ Cr) | 14.1 | 13.48 |
| Net Worth (₹ Cr) | 15.29 | 5.49 |
| RoE (%) | 44.44 | 27.18 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
